케미팜

비상장계속사업자

CHEMIPHARM Co.,LTD

오광택

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

케미팜

Business Reg. No. 1248724013 · CEO 오광택

I.Investment Overview

Target케미팜 (1248724013)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명케미팜
영문명CHEMIPHARM Co.,LTD
대표자오광택
사업자등록번호1248724013
법인등록번호1358110205807
설립일2011.10.04
종업원수9명

V.Workforce

9

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW1402021186.32022203.22023197.82024223.42025
영업이익100M KRW15.8202119.1202215.7202320.5202411.12025
순이익100M KRW13.8202112.4202230.7202313.2202410.72025
Item20252024202320222021
자산총계185.7억원173.5억원196.4억원163.7억원135.6억원
부채총계55.6억원54.1억원90.1억원88.2억원72.4억원
자본총계130.1억원119.4억원106.2억원75.6억원63.2억원
매출액223.4억원197.8억원203.2억원186.3억원140억원
영업이익11.1억원20.5억원15.7억원19.1억원15.8억원
순이익10.7억원13.2억원30.7억원12.4억원13.8억원

VII.Financial Ratios

FY2025 basis

4.98%

영업이익률

4.79%

순이익률

5.76%

ROA

8.22%

ROE

42.73%

부채비율

70.06%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

케미팜 투심보고서 | Alpha Lenz